Corxel

Corteria

This biopharmaceutical company develops therapeutic drugs for patients with obesity and heart failure subpopulations.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Corteria Pharmaceuticals

This biopharmaceutical company develops first-in-class drugs for patients with heart failure subpopulations, obesity and autosomal dominant polycystic kidney disease.

Kailera

This biopharmaceutical company develops injectable and oral therapies for the treatment of obesity and related metabolic conditions.

Arecor

This biotechnology firm develops enhanced biopharmaceutical formulations and medicines for patients with diabetes, obesity and other cardiometabolic diseases.

Resalis Therapeutics

This company develops non-coding RNA therapies to treat metabolic disorders, including obesity and fatty liver disease, for patients with unmet medical needs.

Tanai Therapeutics

This company develops oral small molecule therapeutics targeting energy expenditure pathways to treat obesity and cardiometabolic diseases for patients.

Ousia Pharma

This biotechnology company develops peptide-drug conjugates to treat obesity and cardiometabolic diseases for patients requiring improved metabolic health and weight regulation.